 |
|
|
|
Hoffman-La Roche is one of the world's leading health care companies. Represented in more than 70 countries, the company is widely known for original research and development of innovative pharmaceuticals, vitamins, fine chemicals, and diagnostic equipment. As a leader in Retinoid research, Roche introduced the first oral retinoid in Canada in 1983: Accutane (isotretinoin), considered by many a medical breakthrough for the treatment of acne. Two other oral retinoids followed: Tegison (etretinate) in 1984 and Soriatane (acitretin) in 1994, for the treatment of disorders of keratinization. The Company is active in a broad range of therapeutic categories including dermatology, HIV/AIDS, cardiology, infectious diseases, rheumatology, obesity, Parkinsons, biological response modifier, endocrinology, oncology and virology. Roche Canada employs over 300 people and is part of Hoffman-La Roche Ltd., with Canadian he adquarters in Mississauga , Ontario and International headquarters in Basel , Switzerland.
Click here to close this window |
